P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 209 500 KRW -4.34% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

Gross Margin
PharmaResearch Co Ltd

71.1%
Current
72%
Average
63.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
71.1%
=
Gross Profit
211B
/
Revenue
296.6B

Gross Margin Across Competitors

Country KR
Market Cap 2.2T KRW
Gross Margin
71%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 300.2B USD
Gross Margin
67%
Country US
Market Cap 159.1B USD
Gross Margin
60%
Country US
Market Cap 126.6B USD
Gross Margin
86%
Country US
Market Cap 114.6B USD
Gross Margin
78%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 137.3B AUD
Gross Margin
52%
Country US
Market Cap 87.6B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 34.1B EUR
Gross Margin
89%

Profitability Report

View the profitability report to see the full profitability analysis for PharmaResearch Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
71.1%
=
Gross Profit
211B
/
Revenue
296.6B
What is the Gross Margin of PharmaResearch Co Ltd?

Based on PharmaResearch Co Ltd's most recent financial statements, the company has Gross Margin of 71.1%.